Teladoc Health (NYSE:TDOC) Price Target Cut to $14.00 by Analysts at Evercore ISI

Teladoc Health (NYSE:TDOC) had its price target cut by Evercore ISI from $15.00 to $14.00 in a research note published on Friday, Benzinga reports. They currently have an in-line rating on the health services provider’s stock.

Several other analysts also recently commented on TDOC. TD Cowen reduced their target price on shares of Teladoc Health from $16.00 to $15.00 and set a hold rating for the company in a report on Friday. Cantor Fitzgerald began coverage on shares of Teladoc Health in a report on Thursday, February 29th. They set an overweight rating and a $22.00 target price for the company. SVB Leerink initiated coverage on shares of Teladoc Health in a report on Monday, February 26th. They set a market perform rating and a $17.00 target price for the company. Leerink Partnrs reissued a market perform rating on shares of Teladoc Health in a report on Monday, February 26th. Finally, Citigroup cut their price objective on shares of Teladoc Health from $21.00 to $19.00 and set a neutral rating for the company in a report on Wednesday, February 21st. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of Hold and an average price target of $19.67.

Teladoc Health Stock Down 2.4 %

Teladoc Health stock opened at $13.01 on Friday. The company’s 50-day moving average is $15.01 and its 200-day moving average is $17.77. Teladoc Health has a fifty-two week low of $12.65 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.37) earnings per share. On average, analysts anticipate that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jason N. Gorevic sold 53,755 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the transaction, the chief executive officer now owns 653,073 shares of the company’s stock, valued at $9,482,619.96. The disclosure for this sale can be found here. In the last 90 days, insiders sold 135,441 shares of company stock valued at $2,038,251. Company insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. increased its position in Teladoc Health by 2,130.9% in the 1st quarter. Newbridge Financial Services Group Inc. now owns 11,400 shares of the health services provider’s stock valued at $172,000 after acquiring an additional 10,889 shares during the period. Westside Investment Management Inc. boosted its stake in shares of Teladoc Health by 37.7% in the 1st quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider’s stock valued at $85,000 after purchasing an additional 1,550 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Teladoc Health by 74.0% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after purchasing an additional 8,750 shares during the last quarter. Counterpoint Mutual Funds LLC bought a new stake in shares of Teladoc Health in the 1st quarter valued at $271,000. Finally, Ignite Planners LLC boosted its stake in shares of Teladoc Health by 6.9% in the 1st quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider’s stock valued at $198,000 after purchasing an additional 857 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.